Rawalpindi: BF Biosciences Limited has announced its Annual General Meeting (AGM) is scheduled for October 28, 2026, at 12:15 P.M. The meeting will take place at Blue Lagoon, Masood Akhter Kiani Road, Rawalpindi, and will also be accessible via video-link. This gathering aims to address both ordinary and special business matters concerning the company's operations and governance.

The agenda includes the confirmation of minutes from the previous AGM held on October 25, 2025. Additionally, stakeholders will review and adopt the audited financial statements for the fiscal year ending June 30, 2026. These financials will be accompanied by the Chairman's Review, as well as Directors and Auditors' reports. The appointment of auditors for the following financial year, ending June 30, 2027, will also be on the agenda, including the determination of their remuneration.

A significant component of the AGM will be the discussion of special business. This includes considering and approving related party transactions from the financial year 2025-26. The Board of Directors will seek authorization to approve future related party transactions. Resolutions to ratify and confirm these transactions, as outlined in note 36 of the financial statements for the year ended June 30, 2026, will be presented.

According to information available from the Pakistan Stock Exchange (PSX), the meeting will also entertain any other business that may arise, pending the chair's approval. This is in line with the procedural norms outlined in Section 134(3) of the Companies Act, 2017, which is annexed with the AGM notice.

This upcoming AGM provides an opportunity for BF Biosciences Limited to ensure transparency and engage with its shareholders in strategic decision-making processes.